On July 15, 2021 Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to treat oncology indications, reported it was invited to participate as one of a select group of companies at SVB Leerink’s Biopharma Private Company Connect, taking place virtually on July 21-22nd, 2021 (Press release, Sapience Therapeutics, JUL 15, 2021, View Source [SID1234584887]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Members of Sapience’s management team will participate in one-on-one meetings with life science investors during both days of the event.